The Hebrew University of Jerusalem
Overview
The Hebrew University of Jerusalem is a public research university that engages in the commercialization of its research and invests in spin-off companies, often through its technology transfer arm, Yissum.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ViVac Pharma | Oct 2026 | Grant | Co-investor |
| Tissue Dynamics | Jul 2020 | Seed | Co-investor |
| GemmaCert | Aug 2019 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is The Hebrew University of Jerusalem based?
The Hebrew University of Jerusalem is headquartered in Jerusalem, Israel.
When was The Hebrew University of Jerusalem founded?
The Hebrew University of Jerusalem was founded in 1918.
How many portfolio companies does The Hebrew University of Jerusalem have?
The Hebrew University of Jerusalem has 3 portfolio companies in Caplight's dataset.
What are some companies in The Hebrew University of Jerusalem's portfolio?
Recent investments visible on Caplight include ViVac Pharma, Tissue Dynamics, GemmaCert.
What was The Hebrew University of Jerusalem's most recent investment?
The Hebrew University of Jerusalem's most recent investment on Caplight was in ViVac Pharma in 2026.
What sectors does The Hebrew University of Jerusalem focus on?
The Hebrew University of Jerusalem focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does The Hebrew University of Jerusalem focus on?
The Hebrew University of Jerusalem typically invests at the Mid stage.